Expression of leukotriene B
Animals
Biomarkers
/ metabolism
Cell Differentiation
/ drug effects
Cell Membrane
/ drug effects
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Chemokine CCL21
/ pharmacology
Dendritic Cells
/ drug effects
Dermatitis, Atopic
/ complications
Hypersensitivity
/ complications
Inflammation
/ complications
Interleukin-12
/ biosynthesis
Leukotriene B4
/ metabolism
Lymph Nodes
/ drug effects
Mice, Inbred C57BL
Receptors, Leukotriene B4
/ metabolism
Skin
/ pathology
Th1 Cells
/ drug effects
Transcriptome
/ genetics
BLT1
LTB4
dendritic cells
inflammation
lipid mediator
Journal
Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
24
03
2020
accepted:
11
09
2020
revised:
10
09
2020
pubmed:
11
10
2020
medline:
27
1
2022
entrez:
10
10
2020
Statut:
ppublish
Résumé
Leukotriene B
Identifiants
pubmed: 33037399
doi: 10.1038/s41423-020-00559-7
pii: 10.1038/s41423-020-00559-7
pmc: PMC8167169
doi:
Substances chimiques
Biomarkers
0
Chemokine CCL21
0
Receptors, Leukotriene B4
0
Interleukin-12
187348-17-0
Leukotriene B4
1HGW4DR56D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1437-1449Subventions
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 22116001, 22116002, 15H05901, 15H05904, 15H04708, 18H02627
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 25860223, 15K19032, 17K08664
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 15K08316, 18K06923
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : 15KK0320, 16K08596
Références
GeurtsvanKessel, C. H. et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206, 2339–2349 (2009).
pubmed: 19808255
pmcid: 2768850
Natsuaki, Y. et al. Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat. Immunol. 15, 1064–1069 (2014).
pubmed: 25240383
Natsuaki, Y. & Kabashima, K. Inducible lymphoid clusters, iSALTs, in contact dermatitis: a new concept of acquired cutaneous immune responses. Med. Mol. Morphol. 49, 127–132 (2016).
pubmed: 26941109
Kuroda, E. et al. Inhaled fine particles induce alveolar macrophage death and interleukin-1alpha release to promote inducible bronchus-associated lymphoid tissue formation. Immunity 45, 1299–1310 (2016).
pubmed: 28002730
Yao, C. et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15, 633–640 (2009).
pubmed: 19465928
Boniface, K. et al. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206, 535–548 (2009).
pubmed: 19273625
pmcid: 2699124
Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat. Rev. Drug Discov. 9, 883–897 (2010).
pubmed: 21031003
Kappos, L. et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387–401 (2010).
pubmed: 20089952
Li, H. & Zhang, X. Oral cladribine and fingolimod for relapsing multiple sclerosis. N. Engl. J. Med. 362, 1738–1739 (2010). author reply 1739-40.
pubmed: 20449878
Mann, H. Oral cladribine and fingolimod for relapsing multiple sclerosis. N. Engl. J. Med. 362, 1738 (2010). author reply 1739-40.
pubmed: 20445188
Carroll, W. M. Oral therapy for multiple sclerosis-sea change or incremental step? N. Engl. J. Med. 362, 456–458 (2010).
pubmed: 20089958
Cohen, J. A. et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362, 402–415 (2010).
pubmed: 20089954
Sawada, Y. et al. Resolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses. J. Exp. Med. 212, 1921–1930 (2015).
pubmed: 26438363
pmcid: 4612099
Miki, Y. et al. Lymphoid tissue phospholipase A2 group IID resolves contact hypersensitivity by driving antiinflammatory lipid mediators. J. Exp. Med. 210, 1217–1234 (2013).
pubmed: 23690440
pmcid: 3674707
Yokomizo, T. Leukotriene B4 receptors: novel roles in immunological regulations. Adv. Enzym. Regul. 51, 59–64 (2011).
Yokomizo, T. Two distinct leukotriene B4 receptors, BLT1 and BLT2. J. Biochem. 157, 65–71 (2015).
pubmed: 25480980
Yokomizo, T., Nakamura, M. & Shimizu, T. Leukotriene receptors as potential therapeutic targets. J. Clin. Invest. 128, 2691–2701 (2018).
pubmed: 29757196
pmcid: 6025999
Saeki, K. & Yokomizo, T. Identification, signaling, and functions of LTB4 receptors. Semin. Immunol. 33, 30–36 (2017).
pubmed: 29042026
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620–624 (1997).
pubmed: 9177352
Lammermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498, 371–375 (2013).
pubmed: 23708969
Ichiki, T. et al. Modulation of leukotriene B4 receptor 1 signaling by receptor for advanced glycation end products (RAGE). FASEB J. 30, 1811–1822 (2016).
pubmed: 26813973
Ichiki, T., Koga, T. & Yokomizo, T. Receptor for advanced glycation end products regulates leukotriene B4 receptor 1 signaling. DNA Cell Biol. 35, 747–750 (2016).
pubmed: 27830944
Patnode, M. L., Bando, J. K., Krummel, M. F., Locksley, R. M. & Rosen, S. D. Leukotriene B4 amplifies eosinophil accumulation in response to nematodes. J. Exp. Med. 211, 1281–1288 (2014).
pubmed: 24889202
pmcid: 4076593
Serezani, C. H., Lewis, C., Jancar, S. & Peters-Golden, M. Leukotriene B4 amplifies NF-kappaB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. J. Clin. Invest. 121, 671–682 (2011).
pubmed: 21206089
pmcid: 3026722
Okamoto, F., Saeki, K., Sumimoto, H., Yamasaki, S. & Yokomizo, T. Leukotriene B4 augments and restores Fc gammaRs-dependent phagocytosis in macrophages. J. Biol. Chem. 285, 41113–41121 (2010).
pubmed: 20959460
pmcid: 3003409
Toda, A. et al. Attenuated Th1 induction by dendritic cells from mice deficient in the leukotriene B4 receptor 1. Biochimie 92, 682–691 (2010).
pubmed: 20004699
Del Prete, A. et al. Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood 109, 626–631 (2007).
pubmed: 16985179
pmcid: 1785104
Tager, A. M. et al. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4, 982–990 (2003).
pubmed: 12949531
Goodarzi, K., Goodarzi, M., Tager, A. M., Luster, A. D. & von Andrian, U. H. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4, 965–973 (2003).
pubmed: 12949533
Okuno, T., Ishitani, T. & Yokomizo, T. Biochemical characterization of three BLT receptors in zebrafish. PLoS One 10, e0117888 (2015).
pubmed: 25738285
pmcid: 4349892
Terawaki, K. et al. Absence of leukotriene B4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175, 4217–4225 (2005).
pubmed: 16177061
Kihara, Y. et al. The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis. Biochem. Biophys. Res Commun. 394, 673–678 (2010).
pubmed: 20226760
Wang, L. et al. BLT1-dependent alveolar recruitment of CD4(+)CD25(+) Foxp3(+) regulatory T cells is important for resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 186, 989–998 (2012).
pubmed: 22955313
Sasaki, F. et al. Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1. PLoS One 12, e0185133 (2017).
pubmed: 28922396
pmcid: 5602668
Sasaki, F. et al. Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models. JCI Insight 3, e96902 (2018).
pmcid: 6237215
Tomura, M. et al. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120, 883–893 (2010).
pubmed: 20179354
pmcid: 2827959
Scholzen, T. E. et al. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J. 18, 1007–1009 (2004).
pubmed: 15084523
Kikuta, J. et al. Dynamic visualization of RANKL and Th17-mediated osteoclast function. J. Clin. Invest. 123, 866–873 (2013).
pubmed: 23321670
pmcid: 3561830
Suzuki, K., Grigorova, I., Phan, T. G., Kelly, L. M. & Cyster, J. G. Visualizing B cell capture of cognate antigen from follicular dendritic cells. J. Exp. Med. 206, 1485–1493 (2009).
pubmed: 19506051
pmcid: 2715076
Cohn, L. & Delamarre, L. Dendritic cell-targeted vaccines. Front. Immunol. 5, 255 (2014).
pubmed: 24910635
pmcid: 4039009
Miller, J. C. et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13, 888–899 (2012).
pubmed: 22797772
pmcid: 3985403
Granucci, F. et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2, 882–888 (2001).
pubmed: 11526406
Zhou, J. et al. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis. Cell Mol. Immunol. 15, 1047–1056 (2018).
pubmed: 29670278
pmcid: 6269524
Matsunaga, Y. et al. Leukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophilia. FASEB J. 27, 3306–3314 (2013).
pubmed: 23603839
Gelfand, E. W. Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma. Semin Immunol. 33, 44–51 (2017).
pubmed: 29042028
pmcid: 5679233
Peters-Golden, M. Expanding roles for leukotrienes in airway inflammation. Curr. Allergy Asthma. Rep. 8, 367–373 (2008).
pubmed: 18606091
Niimi, A. Cough, asthma, and cysteinyl-leukotrienes. Pulm. Pharm. Ther. 26, 514–519 (2013).
Hori, T. et al. Na(+)-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1. Nat. Chem. Biol. 14, 262–269 (2018).
pubmed: 29309055
Kato, K., Yokomizo, T., Izumi, T. & Shimizu, T. Cell-specific transcriptional regulation of human leukotriene B(4) receptor gene. J. Exp. Med. 192, 413–420 (2000).
pubmed: 10934229
pmcid: 2193224
Chen, C. J., Hou, J. W. & Chiang, B. L. The difference in immune response and IL-12p35 methylation between newborns and adults. J. Biomed. Sci. 21, 76 (2014).
pubmed: 25139335
pmcid: 4237803
Schaller, M. et al. Epigenetic regulation of IL-12-dependent T cell proliferation. J. Leukoc. Biol. 98, 601–613 (2015).
pubmed: 26059830
pmcid: 4763868
Xu, J. et al. Nuclear carbonic anhydrase 6B associates with PRMT5 to epigenetically promote IL-12 expression in innate response. Proc. Natl Acad. Sci. USA 114, 8620–8625 (2017).
pubmed: 28739930
Li, M. F. et al. High glucose increases the expression of inflammatory cytokine genes in macrophages through H3K9 methyltransferase mechanism. J. Interferon Cytokine Res 36, 48–61 (2016).
pubmed: 26406561
Bandyopadhyay, S., Montagna, C. & Macian, F. Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells. Eur. J. Immunol. 42, 2471–2483 (2012).
pubmed: 22684523
pmcid: 3681531
Wang, J., Barke, R. A. & Roy, S. Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J. Biol. Chem. 282, 7164–7171 (2007).
pubmed: 17227776
Nagatake, T. et al. Immunological association of inducible bronchus-associated lymphoid tissue organogenesis in Ag85B-rHPIV2 vaccine-induced anti-tuberculosis mucosal immune responses in mice. Int. Immunol. 30, 471–481 (2018).
pubmed: 30011025
pmcid: 6153728
Scandella, E., Men, Y., Gillessen, S., Forster, R. & Groettrup, M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100, 1354–1361 (2002).
pubmed: 12149218
Scandella, E. et al. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 103, 1595–1601 (2004).
pubmed: 14592837
Legler, D. F., Krause, P., Scandella, E., Singer, E. & Groettrup, M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176, 966–973 (2006).
pubmed: 16393982
Yen, J. H., Khayrullina, T. & Ganea, D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood 111, 260–270 (2008).
pubmed: 17925490
pmcid: 2200811
Kabashima, K. et al. Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells. Nat. Med. 9, 744–749 (2003).
pubmed: 12740571